|
In women with breast cancer, a history of taking menopausal hormone therapy (MHT) before diagnosis was associated with a 23% to 43% reduction in risk of all-cause mortality and mortality from breast cancer and cardiovascular disease (CVD), according to results from the Long Island Breast Cancer Study Project (LIBCSP).
|